Significance of the response of quiescent cell populations within solid tumors in cancer therapy.

In analyzing the response of quiescent (Q) cells in solid tumors, we have developed a combined method with a micronucleus (MN) assay and the identification of proliferating (P) cells by 5-bromo-2'-deoxyuridine (BrdU) and an anti-BrdU monoclonal antibody. Using this method, the responses of Q tumor cells as well as total tumor (P + Q) cells within murine solid tumors to various DNA-damaging treatments were evaluated. Based on this evaluation, combining with tirapazamine, a well-known bioreductive agent, and/or heat treatment at mild temperatures was thought to be a promising modality for cancer therapy in terms of conventional anticancer treatment-resistant Q cell control. Recently, our method for detecting the Q-cell response using P cell labeling with BrdU and the MN frequency assay was also shown to be applicable to an apoptosis detection assay. Meanwhile, our method for detecting the intratumor Q-cell response was also applicable toward high linear energy transfer radiation, including reactor neutrons. Thus, using our method, a new neutron capture compound that has the potential to be distributed in neutron capture therapy-resistant intratumor Q cell populations is now under development.

• Publication year

  2002

• Venue

  Journal of Radiation Research

• Publication date

  2002-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1269/JRR.43.11PMID 12056326
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Arrhenius relationships from the molecule and cell to the clinic

  2009cited by this paper
• An attempt to enhance chemosensitivity of quiescent cell populations in solid tumors by combined treatment with nicotinamide and carbogen

  2005cited by this paper
• Radiobiologic significance of apoptosis and micronucleation in quiescent cells within solid tumors following gamma-ray irradiation.

  2001cited by this paper
• Radiosensitization effect by combination with paclitaxel in vivo, including the effect on intratumor quiescent cells.

  2001cited by this paper
• Evaluation of apoptosis and micronucleation induced by reactor neutron beams with two different cadmium ratios in total and quiescent cell populations within solid tumors.

  2001cited by this paper
• Evaluation of the Potential of p‐Boronophenylalaninol as a Boron Carrier in Boron Neutron Capture Therapy, Referring to the Effect on Intratumor Quiescent Cells

  2001cited by this paper
• Time course of reoxygenation in experimental murine tumors after carbon-beam and X-ray irradiation.

  2001cited by this paper
• Can gene therapy overcome the problem of hypoxia in radiotherapy?

  2000cited by this paper
• Sigma-2 receptors as a biomarker of proliferation in solid tumours

  2000cited by this paper
• Changes in the Sensitivity of Intratumor Cells during Fractionated Tirapazamine Administration

  2000cited by this paper
• Usefulness of Tirapazamine as a Combined Agent in Chemoradiation and Thermo‐chemoradiation Therapy at Mild Temperatures: Reference to the Effect on Intratumor Quiescent Cells

  2000cited by this paper
• Alteration of sensitivity of intratumor quiescent and total cells to gamma-rays following thermal neutron irradiation with or without 10B-compound.

  2000cited by this paper
• Change in oxygenation status in intratumour total and quiescent cells following gamma-ray irradiation, tirapazamine administration, cisplatin injection and bleomycin treatment.

  2000cited by this paper
• Combined effects of tirapazamine and mild hyperthermia on anti-angiogenic agent (TNP-470) treated tumors-reference to the effect on intratumor quiescent cells.

  2000cited by this paper
• Potentially lethal damage repair by total and quiescent tumor cells following various DNA-damaging treatments.

  1999cited by this paper
• Reoxygenation in quiescent and total intratumor cells following thermal neutron irradiation with or without (10)B-compound-compared with that after gamma-ray irradiation.

  1999cited by this paper
• The radiation biology of boron neutron capture therapy.

  1999cited by this paper
• Repair of potentially lethal damage by total and quiescent cells in solid tumors following a neutron capture reaction

  1999cited by this paper
• The hypoxic cell: a target for selective cancer therapy--eighteenth Bruce F. Cain Memorial Award lecture.

  1999cited by this paper
• Development of new boron carriers for BNCT. Synthesis and biological evaluation of both enantiomers of p-boronophenylalaninol

  1999cited by this paper
• Modification of tirapazamine-induced cytotoxicity in combination with mild hyperthermia and/or nicotinamide: reference to effect on quiescent tumour cells.

  1999cited by this paper
• Simultaneous evaluation of radiation-induced apoptosis and micronuclei in five cell lines.

  1998cited by this paper
• Responses of Total and Quiescent Cell Populations in Solid Tumors to Boron and Gadolinium Neutron Capture Reaction Using Neutrons with Two Different Energy Spectra

  1998cited by this paper
• Applicability of Combination with Tirapazamine in Boron Neutron Capture Therapy

  1998cited by this paper
• Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low-temperature hyperthermia.

  1998cited by this paper
• The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.

  1998cited by this paper
• Response of quiescent and total tumor cells in solid tumors to neutrons with various cadmium ratios.

  1998cited by this paper
• The tumor microenvironment: a double-edged sword.

  1998cited by this paper
• Alteration in the hypoxic fraction of quiescent cell populations by hyperthermia at mild temperatures.

  1997cited by this paper
• Modification of the response of a quiescent cell population within a murine solid tumour to boron neutron capture irradiation: studies with nicotinamide and hyperthermia.

  1997cited by this paper
• Augmentation in Chemosensitivity of Intratumor Quiescent Cells by Combined Treatment with Nicotinamide and Mild Hyperthermia

  1997cited by this paper
• Effects of Bioreductive Agents, Tirapazamine and Mitomycin C, on Quiescent Cell Populations in Solid Tumors, Evaluated by Micronucleus Assay

  1997cited by this paper
• Reduction of hypoxic cells in solid tumours induced by mild hyperthermia: special reference to differences in changes in the hypoxic fraction between total and quiescent cell populations.

  1997cited by this paper
• Determination and drug modification assessed by micronucleus frequency assay of potentially lethal damage repair in quiescent cell populations within murine solid tumors.

  1997cited by this paper
• Apoptosis and mitotic cell death: their relative contributions to normal-tissue and tumour radiation response.

  1997cited by this paper
• Sigma 2 receptors as potential biomarkers of proliferation in breast cancer.

  1997cited by this paper
• Tirapazamine: hypoxic cytotoxicity and interaction with radiation as assessed by the micronucleus assay.

  1996cited by this paper
• p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts.

  1995cited by this paper
• Eugene Robertson Special Lecture. Hyperthermia from the clinic to the laboratory: a hypothesis.

  1995cited by this paper
• Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology.

  1995cited by this paper
• Tumor suppressor p53 is a direct transcriptional activator of the human bax gene.

  1995cited by this paper
• p53-Dependent apoptosis in the absence of transcriptional activation of p53-target genes

  1994cited by this paper
• The radiosensitivity of quiescent cell populations in murine solid tumors in irradiation with fast neutrons.

  1994cited by this paper
• Evaluation of response to thermal neutron irradiation in quiescent cell populations within murine solid tumors using micronucleus assay

  1994cited by this paper
• Increased expression of the matrix metalloproteinase 2 in differentiating tera 2 human embryonal carcinoma cells

  1994cited by this paper
• The response of quiescent cell populations in murine solid tumors to irradiation with fast neutrons.

  1994cited by this paper
• Enhancement of chemosensitivity of quiescent cell populations in murine solid tumors using nicotinamide

  1994cited by this paper
• p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.

  1994cited by this paper
• SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours.

  1993cited by this paper
• The detection and modification of the hypoxic fraction in quiescent cell populations in murine solid tumours.

  1993cited by this paper
• Design and preparation of ethyl cellulose microcapsules of gadopentetate dimeglumine for neutron-capture therapy using the Wurster process.

  1993cited by this paper
• Heterogeneity in the development of apoptosis in irradiated murine tumours of different histologies.

  1993cited by this paper
• Alteration of Radiosensitivity of Quiescent Cell Populations in Solid Tumors Irradiated with X‐Rays Twice at Various Intervals

  1993cited by this paper
• Multivariate analysis of prognostic factors in patients with non HIV-related primary cerebral lymphoma. A proposal for a prognostic scoring.

  1993cited by this paper
• WAF1, a potential mediator of p53 tumor suppression.

  1993cited by this paper
• The detection and modification of the hypoxic fraction in quiescent cell populations in murine solid tumours

  1993cited by this paper
• The determination of the hypoxic fraction and clonogenicity of proliferating and quiescent cell populations in murine solid tumors

  1993cited by this paper
• Enhancement of chemosensitivity of quiescent cell populations in murine solid tumors using nicotinamide.

  1993cited by this paper
• A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.

  1992cited by this paper
• Potentially lethal damage repair by quiescent cells in murine solid tumors.

  1992cited by this paper
• Analysis of radiation-induced micronuclei by fluorescence in situ hybridization (FISH) simultaneously using telomeric and centromeric DNA probes.

  1992cited by this paper
• A method for the selective measurement of the radiosensitivity of quiescent cells in solid tumors--combination of immunofluorescence staining to BrdU and micronucleus assay.

  1991cited by this paper
• Pathophysiological Mechanisms of Hyperthermia in Cancer Therapy

  1990cited by this paper
• Micronuclei in cytokinesis-blocked lymphocytes of cancer patients following fractionated partial-body radiotherapy.

  1990cited by this paper
• Use of the micronucleus assay for the selective detection of radiosensitivity in BUdR-unincorporated cells after pulse-labelling of exponentially growing tumour cells.

  1990cited by this paper
• Delivery of novel therapeutic agents in tumors: physiological barriers and strategies.

  1990cited by this paper
• Evaluation of cell subpopulations isolated from human tumor xenografts by centrifugal elutriation.

  1990cited by this paper
• Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts.

  1989cited by this paper
• Radiation-induced DNA damage and repair in quiescent and proliferating human tumor cells in vitro.

  1989cited by this paper
• Characterization of radiation resistant hypoxic cell subpopulations in KHT sarcomas. (II). Cell sorting.

  1988cited by this paper
• Characterization of radiation resistant hypoxic cell subpopulations in KHT sarcomas. (I). Centrifugal elutriation.

  1987cited by this paper
• Heterogeneity of X-ray cytotoxicity in proliferating and quiescent murine mammary carcinoma cells.

  1985cited by this paper
• Murine Mammary Tumour Cells In Vitro. I. the Development of A Quiescent State

  1984cited by this paper
• The detection and measurement of hypoxic cells in solid tumors

  1984cited by this paper
• Murine Mammary Tumour Cells In Vitro. Ii. Recruitment of Quiescent Cells

  1984cited by this paper
• Isolation of quiescent cells from multicellular tumor spheroids using centrifugal elutriation.

  1982cited by this paper
• Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation.

  1979cited by this paper
• Collective and two-quasiparticle states in 158Gd observed through study of radiative neutron capture in 157Gd

  1978cited by this paper
• ON THE CONCEPT OF THE CELL CYCLE.

  1963cited by this paper

• Equivalent relative biological effectiveness for cell survival and micronuclei formation: insights from a biophysical approach

  2025cites this paper
• ‘Cell knife’ for cancer: the clinician’s perspective

  2025cites this paper
• Mathematical modeling of radiotherapy and its impact on tumor interactions with the immune system

  2022cites this paper
• Importance of radiobiological studies for the advancement of boron neutron capture therapy (BNCT)

  2022cites this paper
• Preclinical study of boron neutron capture therapy for bone metastasis using human breast cancer cell lines.

  2020cites this paper
• Effect of a change in reactor power on response of murine solid tumors in vivo, referring to impact on quiescent tumor cell population

  2019cites this paper
• Modeling and histopathological recognition of anoikis resistance in colorectal carcinoma

  2019cites this paper
• Translational boron neutron capture therapy (BNCT) studies for the treatment of tumors in lung

  2019cites this paper
• Micropapillary Structures in Colorectal Cancer: An Anoikis-resistant Subpopulation.

  2018cites this paper
• The Effect of p53 Status on Radio-Sensitivity of Quiescent Tumor Cell Population Irradiated With γ-Rays at Various Dose Rates

  2018cites this paper
• Title The dependency of compound biological effectiveness factors on the type and the concentration of administered neutron capture agents in boron neutron capture therapy

  2017cites this paper
• Effect of Tirapazamine, Metformin or Mild Hyperthermia on Recovery From Radiation-Induced Damage in Pimonidazole-Unlabeled Quiescent Tumor Cells

  2017cites this paper
• RBE and related modeling in carbon-ion therapy

  2017cites this paper
• Effect of oxygen pressure during incubation with a 10B-carrier on 10B uptake capacity of cultured p53 wild-type and mutated tumor cells: dependency on p53 status of tumor cells and types of 10B-carriers

  2016cites this paper
• The Effect of p53 Status of Tumor Cells on Radiosensitivity of Irradiated Tumors With Carbon-Ion Beams Compared With γ-Rays or Reactor Neutron Beams

  2015cites this paper
• Boron neutron capture therapy (BNCT) as a new approach for clear cell sarcoma (CCS) treatment: Trial using a lung metastasis model of CCS.

  2015cites this paper
• Determination of the relative biological effectiveness and oxygen enhancement ratio for micronuclei formation using high-LET radiation in solid tumor cells: An in vitro and in vivo study.

  2015cites this paper
• Boron neutron capture therapy as new treatment for clear cell sarcoma: trial on different animal model.

  2014cites this paper
• Significance of Fractionated Administration of Thalidomide Combined With γ-Ray Irradiation in Terms of Local Tumor Response and Lung Metastasis

  2014cites this paper
• The dependency of compound biological effectiveness factors on the type and the concentration of administered neutron capture agents in boron neutron capture therapy

  2014cites this paper
• Forkhead Box M1 Regulates Quiescence-Associated Radioresistance of Human Head and Neck Squamous Carcinoma Cells

  2014cites this paper
• Effect of bevacizumab combined with boron neutron capture therapy on local tumor response and lung metastasis

  2014cites this paper
• Enhancement of the uptake and cytotoxic activity of doxorubicin in cancer cells by novel cRGD-semipeptide-anchoring liposomes.

  2014cites this paper
• SEPP1 and FoxM1 regulate oxidative stress-mediated radiation response

  2013cites this paper
• Effect of Tirapazamine and Mild Temperature Hyperthermia on the Recovery from Radiation-Induced Damage in Pimonidazole-Unlabeled Quiescent Tumor Cell Population

  2013cites this paper
• Usefulness of Daily Fractionated Administration of Wortmannin Combined With γ-Ray Irradiation in Terms of Local Tumor Response and Lung Metastasis

  2013cites this paper
• Evaluation of SCCVII tumor cell survival in clamped and non-clamped solid tumors exposed to carbon-ion beams in comparison to X-rays.

  2013cites this paper
• Development of (18)F-labeled PET probes for imaging cell proliferation.

  2013cites this paper
• Radiosensitivity of pimonidazole-unlabelled intratumour quiescent cell population to γ-rays, accelerated carbon ion beams and boron neutron capture reaction.

  2013cites this paper
• The σ2 receptor: a novel protein for the imaging and treatment of cancer.

  2013cites this paper
• Usefulness of combined treatment with continuous administration of tirapazamine and mild temperature hyperthermia in γ-ray irradiation in terms of local tumour response and lung metastatic potential

  2012cites this paper
• Evaluating the Usefulness of a Novel 10B-Carrier Conjugated With Cyclic RGD Peptide in Boron Neutron Capture Therapy

  2012cites this paper
• Wortmannin efficiently suppresses the recovery from radiation-induced damage in pimonidazole-unlabeled quiescent tumor cell population

  2012influential citation
• Effects of employing a ¹⁰B-carrier and manipulating intratumour hypoxia on local tumour response and lung metastatic potential in boron neutron capture therapy.

  2012cites this paper
• MRI-guided neutron capture therapy by use of a dual gadolinium/boron agent targeted at tumour cells through upregulated low-density lipoprotein transporters.

  2011cites this paper
• Radiosensitivity and Capacity to Recover from Radiation-Induced Damage in Pimonidazole-Unlabeled Intratumor Quiescent Cells Depend on p53 Status

  2011cites this paper
• Induction of DNA DSB and its rejoining in clamped and non-clamped tumours after exposure to carbon ion beams in comparison to X rays.

  2011cites this paper
• Reducing intratumour acute hypoxia through bevacizumab treatment, referring to the response of quiescent tumour cells and metastatic potential.

  2011cites this paper
• Recent advances in the biology of heavy-ion cancer therapy.

  2010cites this paper
• Usefulness of hexamethylenetetramine as an adjuvant to radiation and cisplatin in the treatment of solid tumors: its independency of p53 status.

  2010cites this paper
• Influence of manipulating hypoxia in solid tumors on the radiation dose-rate effect in vivo, with reference to that in the quiescent cell population

  2010cites this paper
• Adverse effect of mild temperature hyperthermia combined with hexamethylenetetramine compared to its effect combined with tirapazamine in the treatment of solid tumors.

  2010cites this paper
• Significance of manipulating tumour hypoxia and radiation dose rate in terms of local tumour response and lung metastatic potential, referring to the response of quiescent cell populations.

  2010cites this paper
• Evaluation of the Radiosensitivity of the Oxygenated Tumor Cell Fractions in Quiescent Cell Populations within Solid Tumors

  2010cites this paper
• Recent insights into the biological action of heavy-ion radiation.

  2009cites this paper
• Evaluation of the potential of hexamethylenetetramine, compared with tirapazamine, as a combined agent with {gamma}-irradiation and cisplatin treatment in vivo.

  2009cites this paper
• Significance of manipulating intratumor hypoxia in the effect on lung metastases in radiotherapy, with reference to its effect on the sensitivity of intratumor quiescent cells

  2009influential citation
• Usefulness of hexamethylenetetramine in combination with chemotherapy using free and pegylated liposomal doxorubicin in vivo, referring to the effect on quiescent cells.

  2009cites this paper
• The effect of post-irradiation tumor oxygenation status on recovery from radiation-induced damage in vivo: with reference to that in quiescent cell populations

  2009influential citation
• Radiobiologic significance of response of intratumor quiescent cells in vivo to accelerated carbon ion beams compared with gamma-rays and reactor neutron beams.

  2008cites this paper
• Brachytherapy for oral tongue cancer: an analysis of treatment results with various biological markers.

  2008cites this paper
• The radiosensitivity of total and quiescent cell populations in solid tumors to 290 MeV/u carbon ion beam irradiation in vivo

  2008cites this paper
• Chromosome fragments have the potential to predict hyperthermia-induced radio-sensitization in two different human tumor cell lines.

  2008cites this paper
• Responses of total and quiescent cell populations in solid tumors to carbon ion beam irradiation (290 MeV/u) in vivo

  2008cites this paper
• The usefulness of mild temperature hyperthermia combined with continuous tirapazamine administration under reduced dose–rate irradiation with γ-rays

  2007cites this paper
• Inhibition of repair of radiation-induced damage by mild temperature hyperthermia, referring to the effect on quiescent cell populations

  2007cites this paper
• Dependency of repair of radiation-induced damage on p53 status and efficient inhibition of the repair with wortmannin treatment in vivo, with reference to the effect on intratumor quiescent cell population.

  2007cites this paper
• Design of hypoxia-targeting drugs as new cancer chemotherapeutics.

  2006cites this paper
• Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.

  2006influential citation
• Dependency of the effect of a vascular disrupting agent on sensitivity to tirapazamine and γ-ray irradiation upon the timing of its administration and tumor size, with reference to the effect on intratumor quiescent cells

  2006cites this paper
• The usefulness of mild temperature hyperthermia combined with a newly developed hypoxia-oriented 10B conjugate compound, TX-2100, for boron neutron capture therapy

  2006cites this paper
• The usefulness of a continuous administration of tirapazamine combined with reduced dose-rate irradiation using {gamma}-rays or reactor thermal neutrons.

  2006cites this paper
• Evaluation of hypoxia-specific cytotoxic bioreductive agent-sodium borocaptate-10B conjugates as10B-carriers in boron neutron capture therapy

  2006cites this paper
• The potential of transferrin-pendant-type polyethyleneglycol liposomes encapsulating decahydrodecaborate-(10)B (GB-10) as (10)B-carriers for boron neutron capture therapy.

  2006cites this paper
• The usefulness of continuous administration of hypoxic cytotoxin combined with mild temperature hyperthermia, with reference to effects on quiescent tumour cell populations

  2005cites this paper
• Effects of mild temperature hyperthermia and p53 status on the size of hypoxic fractions in solid tumors, with reference to the effect in intratumor quiescent cell populations.

  2004cites this paper
• Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.

  2004cites this paper
• Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.

  2004cites this paper
• Usefulness of combined treatment with mild temperature hyperthermia and/or tirapazamine in the treatment of solid tumors: its independence of p53 status

  2003cites this paper
• Oxygen delivery in irradiated normal tissue.

  2003cites this paper